4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-013982
PRESIDENT AND CEO gave up 11,855 shares (to pay taxes)
- PRESIDENT AND CEO acquired 48,679 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise | +6,758 | 5,231,669 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Shares withheld for taxes | −1,646 | $2.69 | $4,428 | 5,230,023 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise | +7,854 | 5,237,877 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Shares withheld for taxes | −1,913 | $2.69 | $5,146 | 5,235,964 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise | +14,733 | 5,250,697 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Shares withheld for taxes | −3,588 | $2.69 | $9,652 | 5,247,109 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise | +19,334 | 5,266,443 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Shares withheld for taxes | −4,708 | $2.69 | $12,665 | 5,261,735 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise · Restricted Stock Units | −6,758 | 18,030 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise · Restricted Stock Units | −7,854 | 86,399 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise · Restricted Stock Units | −14,733 | 250,473 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-05-19 | Option exercise · Restricted Stock Units | −19,334 | 444,703 | D | ||
Loading xslF345X05/form4-05212025_090536.xml…